Skip to main content

Novozymes cuts long-term forecast

Enzymes group saw annual organic sales growth of 6-7 percent through to 2020, down from its earlier the 8-10 percent target.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.